Abstract
Neurodegenerative diseases are known to be associated with genetic and environmental factors. The multifactorial Parkinson’s disease (PD) is triggered and/or further worsened by exposure to certain pesticides. Existing literature suggests a link between pesticide exposure and increased incidence of PD. We carried out the present study to look into the stress gene expression pattern of transgenic Caenorhabditis elegans (C. elegans) model of PD after exposure to pesticides from different classes. Expression level of sod-1, sod-2, sod-3, hsp-70, hsp-60, and hsp-16.2 stress responsive genes was determined using qPCR. Our findings demonstrate that the expression of stress related genes does not follow a generalized pattern to different toxicants; rather each pesticide class has a specific expression signature.
Keywords: Pesticides, Parkinson’s disease, stress genes, Caenorhabditis elegans, Neurodegenerative diseases, toxicants, hypochlorite, pathological, pyrethroid cypermethrin, rotenone treatment.
CNS & Neurological Disorders - Drug Targets
Title:Effect of Various Classes of Pesticides on Expression of Stress Genes in Transgenic C. elegans Model of Parkinson’s Disease
Volume: 11 Issue: 8
Author(s): Pooja Jadiya, Snober S. Mir and Aamir Nazir
Affiliation:
Keywords: Pesticides, Parkinson’s disease, stress genes, Caenorhabditis elegans, Neurodegenerative diseases, toxicants, hypochlorite, pathological, pyrethroid cypermethrin, rotenone treatment.
Abstract: Neurodegenerative diseases are known to be associated with genetic and environmental factors. The multifactorial Parkinson’s disease (PD) is triggered and/or further worsened by exposure to certain pesticides. Existing literature suggests a link between pesticide exposure and increased incidence of PD. We carried out the present study to look into the stress gene expression pattern of transgenic Caenorhabditis elegans (C. elegans) model of PD after exposure to pesticides from different classes. Expression level of sod-1, sod-2, sod-3, hsp-70, hsp-60, and hsp-16.2 stress responsive genes was determined using qPCR. Our findings demonstrate that the expression of stress related genes does not follow a generalized pattern to different toxicants; rather each pesticide class has a specific expression signature.
Export Options
About this article
Cite this article as:
Jadiya Pooja, S. Mir Snober and Nazir Aamir, Effect of Various Classes of Pesticides on Expression of Stress Genes in Transgenic C. elegans Model of Parkinson’s Disease, CNS & Neurological Disorders - Drug Targets 2012; 11 (8) . https://dx.doi.org/10.2174/1871527311211080009
DOI https://dx.doi.org/10.2174/1871527311211080009 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dynamic Role of Macrophage Sub Types on Development of Atherosclerosis
and Potential Use of Herbal Immunomodulators as Imminent
Therapeutic Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry Cdk5 in the Adult Non-Demented Brain
Current Drug Targets - CNS & Neurological Disorders Effective Delivery Routes and Strategies for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)
Current Pharmaceutical Design Editorial [Hot Topic: Strategies to Treat Substance Abuse and Addiction (Guest Editor: Christopher R. McCurdy)]
Current Topics in Medicinal Chemistry Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond
Current Pharmaceutical Biotechnology Editorial [Hot topic: Tau, Neurodegeneration and Alzheimers Disease (Guest Editor: Alejandra del Carmen Alonso)]
Current Alzheimer Research Editorial [Hot topic:Pharmacological Brain Imaging in the Healthy and Sick Brain (Executive Editor: F.M. Van Der Veen)]
Current Pharmaceutical Design Efficacy of Montelukast as Added Therapy in Patients with Chronic Idiopathic Urticaria
Inflammation & Allergy - Drug Targets (Discontinued) Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Allosteric Modulation of Nicotinic Acetylcholine Receptors: The Concept and Therapeutic Trends
Current Pharmaceutical Design Reducing Rifle Bolt Carrier Bounce
Recent Patents on Mechanical Engineering Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication
Current Drug Metabolism 1'-methylspiro[indoline-3,4'-piperidine] Derivatives: Design, Synthesis, Molecular Docking and Anti-tumor Activity Studies
Letters in Drug Design & Discovery Patterns of Acute Intracranial Hemorrhage in Adult Patients with Bilateral and Unilateral Moyamoya Disease
Current Neurovascular Research The Fate of Nanocarriers As Nanomedicines In Vivo: Important Considerations and Biological Barriers to Overcome
Current Medicinal Chemistry Herbal Medicine in the Treatment of Epilepsy
Current Drug Targets Structural and Functional Characterization of Pathogenic Non- Synonymous Genetic Mutations of Human Insulin-Degrading Enzyme by In Silico Methods
CNS & Neurological Disorders - Drug Targets Amine Oxidase Inhibitors and Development of Neuroprotective Drugs
Current Neuropharmacology Neurodegeneration and Neurogenesis: Focus on Alzheimers Disease
Current Alzheimer Research Investigation on the Development of Losartan Potassium Sustained Release Microspheres by Solvent Evaporation Methods
Micro and Nanosystems